Interestingly, between days 4 and 6 post-infection, a big difference could be observed in the survival rates between the groups treated with the recombinant virus expressing the target gene sequences (RPS13, Vha26, and alpha COP) compared to the control groups (FHV eGFP, FHV WT, Medium and Water) (Figure 6A). This evidence concerns the gene RPS13 and infection.